Liang, Naixin
Li, Bingsi
Jia, Ziqi
Wang, Chenyang
Wu, Pancheng
Zheng, Tao
Wang, Yanyu
Qiu, Fujun
Wu, Yijun
Su, Jing
Xu, Jiayue
Xu, Feng
Chu, Huiling
Fang, Shuai
Yang, Xingyu
Wu, Chengju
Cao, Zhili
Cao, Lei
Bing, Zhongxing
Liu, Hongsheng
Li, Li
Huang, Cheng
Qin, Yingzhi
Cui, Yushang
Han-Zhang, Han
Xiang, Jianxing
Liu, Hao
Guo, Xin
Li, Shanqing http://orcid.org/0000-0002-4320-8739
Zhao, Heng http://orcid.org/0000-0001-8122-7992
Zhang, Zhihong http://orcid.org/0000-0002-1454-1604
Funding for this research was provided by:
Natural Science Foundation of Beijing Municipality (7182132)
Article History
Received: 7 October 2019
Accepted: 13 May 2021
First Online: 15 June 2021
Change Date: 30 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-021-00818-6
Competing interests
: T.Z., B.L. and Z.Z. are inventors on a pending patent application held by Burning Rock Biotech related to target deep methylation sequencing (WO2019192489A1, filed in the United States, Canada, Europe, Japan, Sigapore, Australia and Brazil). C. Wang., B.L. and Z.Z. are on a patent application to be submitted by Burning Rock Biotech that covers other aspects of ELSA-seq described in this article.